Tactile Systems Technology (TCMD) Stock Price, News & Analysis

Company Overview

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company focused on developing, manufacturing and distributing devices for people with chronic swelling and respiratory conditions. Its products are intended for use in the home and are commonly prescribed by health care professionals as part of ongoing disease-management programs.

The company’s core products include the Flexitouch pneumatic compression system, designed to support the treatment of lymphedema and related conditions, and the Entre system, which provides pneumatic compression therapy for the upper and lower extremities. Tactile Medical also offers the AffloVest wearable high-frequency chest wall oscillation system, which is designed to help mobilize pulmonary secretions for patients with certain respiratory disorders.

Founded in 1995 and headquartered in Minneapolis, Minnesota, Tactile Medical primarily serves patients and health care providers in the United States. Its products are distributed through a combination of direct sales, clinical support and reimbursement services, with the company working to help patients obtain and use prescribed therapy in their homes.

Key Stats

• Today's Range: $21.61 to $22.43
• 50-Day Range: $21.71 to $30.14
• 52-Week Range: $14.00 to $37.77
• Volume: 252,304 shs
• Average Volume: 263,325 shs
• Market Capitalization: $500.57 million
• P/E Ratio: 20.46
• Dividend Yield: N/A
• Price Target: $38.40
• Consensus Rating: Moderate Buy

Tactile Systems Technology Stock Analysis - MarketRank™

Tactile Systems Technology scored higher than 78% of companies evaluated by MarketBeat, and ranked 150th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Tactile Systems Technology has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 4 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

Tactile Systems Technology has a consensus price target of $38.40, representing about 73.8% upside from its current price of $22.10.

Amount of Analyst Coverage

Tactile Systems Technology has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 22.73%

Earnings Growth

Earnings for Tactile Systems Technology are expected to grow by 22.73% in the coming year, from $1.10 to $1.35 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Tactile Systems Technology is 20.46, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tactile Systems Technology is 20.46, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.69.

Price to Book Value per Share Ratio

Tactile Systems Technology has a P/B Ratio of 2.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.69% of the float of Tactile Systems Technology has been sold short.

Short Interest Ratio / Days to Cover

Tactile Systems Technology has a short interest ratio ("days to cover") of 10.42, which indicates bearish sentiment.

Change versus previous month

Short interest in Tactile Systems Technology has recently increased by 7.85%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tactile Systems Technology does not currently pay a dividend.

Dividend Growth

Tactile Systems Technology does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: N/A

News Sentiment

Tactile Systems Technology has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Tactile Systems Technology this week, compared to 2 articles on an average week.

MarketBeat Follows

3 people have added Tactile Systems Technology to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Tactile Systems Technology insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $323,192.00 in company stock.

Percentage Held by Insiders

2.10% of the stock of Tactile Systems Technology is held by insiders.

Percentage Held by Institutions

83.43% of the stock of Tactile Systems Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 10/04/2026
• Next Earnings (Estimated): 11/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:TCMD
• CIK: 1027838
• Web: www.tactilemedical.com
• Phone: (612) 355-5100
• Fax: 866-435-3949
• Employees: 1,086
• Year Founded: 2006

Price Target and Rating

• Average Price Target for Tactile Systems Technology: $38.40
• High Price Target: $42.00
• Low Price Target: $35.00
• Potential Upside/Downside: +73.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.08
• Trailing P/E Ratio: 20.46
• Forward P/E Ratio: 20.09
• P/E Growth: N/A
• Net Income: $19.09 million
• Net Margins: 7.10%
• Pretax Margin: 10.66%
• Return on Equity: 11.49%
• Return on Assets: 9.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.12
• Quick Ratio: 3.68

Sales & Book Value

• Annual Sales: $329.52 million
• Price / Sales: 1.52
• Cash Flow: $1.15 per share
• Price / Cash Flow: 19.18
• Book Value: $9.80 per share
• Price / Book: 2.26

Miscellaneous

• Outstanding Shares: 22,650,000
• Free Float: 22,176,000
• Market Cap: $500.57 million
• Optionable: Optionable
• Beta: 0.82